• Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1736 Total Publications

α-Synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment.
Ane Korff, PhD, Changqin Liu, MD, PhD, Carmen Ginghina, MD, Min Shi, PhD, and Jing Zhang, MD, PhD, for the Alzheimer’s Disease Neuroimaging Initiative
2013; Journal Journal of Alzheimer's Disease; vol. 36; no. 4; pp. 679-688; AWUU_d3HdzjauPDbjhql
Latent feature representation with stacked auto-encoder for AD/MCI diagnosis.
Suk, H.-I., Lee, S.-W., & Shen, D.
2013; Journal Brain Structure and Function; pp. 1-19; AWUVHdZzdzjauPDbjhqs doi:10.1007/s00429-013-0687-3
Gaussian mixture model-based noise reduction in resting state fMRI data.
Garg, G., Prasad, G., & Coyle, D.
2013; Journal Journal of Neuroscience Methods; vol. 215; no. 1; pp. 71-77; AWUVHdZzdzjauPDbjhqw doi:10.1016/j.jneumeth.2013.02.015
Regional patterns of atrophy on MRI in Alzheimer’s disease: Neuropsychological features and progression rates in the ADNI cohort.
Duara, R., Loewenstein, D. a., Shen, Q., Barker, W., Greig, M. T., Varon, D., … Dickson, D. W.
2013; Journal Advances in Alzheimer's Disease; vol. 2; no. 4; pp. 135-147; AWUVHdZzdzjauPDbjhq2 doi:10.4236/aad.2013.24019
Higher rates of decline for women and apolipoprotein E epsilon4 carriers.
Holland, D., Desikan, R. S., Dale, a M., & McEvoy, L. K.
2013; Journal American Journal of Neuroradiology; vol. 34; no. 12; pp. 2287-93; AWUVHdZzdzjauPDbjhq6 doi:10.3174/ajnr.A3601
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman, V. a., Carmichael, O. T., Schwarz, C., Tosto, G., Zimmerman, M. E., & Brickman, A. M.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 5; pp. S124-S131; AWUVFyWqwAl_G9zjEvgb doi:10.1016/j.jalz.2012.11.009
Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer’s disease and mild cognitive impairment.
Westman, E., Aguilar, C., Muehlboeck, J.-S., & Simmons, A.
2013; Journal Brain Topography; vol. 26; no. 1; pp. 9-23; AWUVFyWqwAl_G9zjEvgj doi:10.1007/s10548-012-0246-x
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.
Guo, L.-H., Alexopoulos, P., & Perneczky, R.
2013; Journal European Archives of Psychiatry and Clinical Neuroscience; vol. 263; no. 7; pp. 553-60; AWUVFyWqwAl_G9zjEvgl doi:10.1007/s00406-013-0405-4
Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
Dickerson, B. C., & Wolk, D. A.
2013; Journal Frontiers in Aging Neuroscience; vol. 5; pp. 55; AWUVFyWqwAl_G9zjEvgm doi:10.3389/fnagi.2013.00055
Dynamics of brain structure and cognitive function in the Alzheimer’s disease neuroimaging initiative.
Song, X., Mitnitski, A., Zhang, N., Chen, W., & Rockwood, K.
2013; Journal Journal of Neurology, Neurosurgery, and Psychiatry; vol. 84; no. 1; pp. 71-8; AWUVFyWqwAl_G9zjEvgu doi:10.1136/jnnp-2012-303579